Entheon Biomedical to Begin Trading on the Frankfurt Exchange Post published:November 26, 2020 Post category:Press Release
MindMed Announces $25 Million Bought Deal Public Offering, Units Priced at $1.90 Post published:November 25, 2020 Post category:Press Release
Field Trip Health Ltd. Schedules Second Fiscal Quarter 2021 Financial Results Conference Call for Tuesday, December 1, 2020 at 8:00 am ET Post published:November 25, 2020 Post category:Press Release
PharmaTher Provides Update on its Psychedelic Pharmaceuticals Programs Post published:November 24, 2020 Post category:Press Release
Champignon Brands Updates Investors on Changes at the Top Post published:November 24, 2020 Post category:Press Release
MindMed to Launch Albert, A Digital Medicine Division for Psychedelic Medicines Post published:November 24, 2020 Post category:Press Release
ATAI Life Sciences Announces Closing of $125 Million Series C Financing Round Post published:November 23, 2020 Post category:Press Release
Novamind Closes Oversubscribed CAD$10 Million Private Placement Post published:November 23, 2020 Post category:Press Release
Research Suggests Past Antidepressant Usage Reduces Efficacy of MDMA-Assisted Psychotherapy for PTSD Post published:November 23, 2020 Post category:News
BBC Two Programme to Follow Psychedelics vs. Antidepressants Trial Post published:November 22, 2020 Post category:News